Reduction of infectious bursal disease virus replication in cultured cells by proteasome inhibitors

Virus Genes. 2007 Dec;35(3):719-27. doi: 10.1007/s11262-007-0147-3. Epub 2007 Aug 7.

Abstract

Infectious bursal disease virus (IBDV) is the etiological agent of a highly contagious disease in chickens. In a recent report, proteasome inhibitor MG132 has been shown to completely inhibit IBDV-induced apoptosis. This raises the possibility that the ubiquitin-proteasome pathway may be used by the virus to promote viral replication. In this study, we examined the interplay between IBDV replication and the ubiquitin-proteasome pathway in cultured cells. Treatment of DF-1 cells with the proteasome inhibitors MG132 or lactacystin significantly decreased virus release in the supernatant and prevented virus-induced cytopathic effect. Inhibition of the ubiquitin-proteasome pathway did reduce markedly viral RNA transcription and protein translation but not affect virus internalization. We also demonstrated that IBDV activates caspase pathway via triggering the efflux of cytochrome c in mitochondria into cytosol of infected cells. This activity was dose-dependently reduced by proteasome inhibitor treatment. Taken together, our data suggest that proteasome inhibitor reduces IBDV replication through inhibition of viral RNA transcription and protein synthesis, and thus preventing IBDV-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / analogs & derivatives*
  • Acetylcysteine / pharmacology
  • Animals
  • Antiviral Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Line
  • Chick Embryo
  • Chickens
  • Cytopathogenic Effect, Viral / drug effects
  • Fibroblasts / drug effects
  • Fibroblasts / virology
  • Infectious bursal disease virus / growth & development*
  • Leupeptins / pharmacology*
  • Proteasome Inhibitors*
  • Protein Biosynthesis / drug effects
  • RNA, Viral / biosynthesis
  • Transcription, Genetic / drug effects
  • Viral Proteins / biosynthesis
  • Virus Internalization / drug effects

Substances

  • Antiviral Agents
  • Leupeptins
  • Proteasome Inhibitors
  • RNA, Viral
  • Viral Proteins
  • lactacystin
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde
  • Acetylcysteine